SCHEMBL20370705

SCHEMBL20370705

c1ccc(-c2nc(-c3ccccc3)nc(-c3cccc(-c4cc5c(cc4-c4cccc(-c6nc(-c7ccccc7)nc(-c7ccccc7)n6)c4)Sc4nc6ccccc6nc4S5)c3)n2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ ADORA2A P29274 3/20 0.37
▸ ADORA1 P30542 3/20 0.37
▸ MEN1 O00255 5/20 0.36
▸ KMT2A Q03164 5/20 0.36
▸ ALDH1A1 P00352 4/20 0.36
▸ MAPT P10636 3/20 0.36
▸ HPGD P15428 3/20 0.36
▸ LMNA P02545 3/20 0.35
▸ KDM4E B2RXH2 2/20 0.35
▸ ATM Q13315 1/20 0.35
▸ GLA P06280 1/20 0.35
▸ CYP1A2 P05177 3/20 0.35
▸ CYP3A4 P08684 3/20 0.35
▸ CYP2C9 P11712 3/20 0.35
▸ CYP2D6 P10635 2/20 0.35
▸ CYP2C19 P33261 2/20 0.35
▸ HSD17B10 Q99714 2/20 0.35
▸ CLK4 Q9HAZ1 2/20 0.35
▸ USP2 O75604 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20370741 0.87 MEN1 (0.38) L3MBTL1ADORA2AADORA1MEN1KMT2A
SCHEMBL20370753 0.86 ADORA2A (0.33) L3MBTL1ADORA2AADORA1MEN1KMT2A
SCHEMBL20370719 0.83 MET (0.34) L3MBTL1ADORA2AADORA1MEN1KMT2A
SCHEMBL20370720 0.81 PIK3CA (0.38) L3MBTL1ADORA2AADORA1MEN1KMT2A
SCHEMBL20370680 0.80 MEN1 (0.40) L3MBTL1ADORA2AADORA1MEN1KMT2A
SCHEMBL20370739 0.78 CYP1A2 (0.33) L3MBTL1ADORA2AADORA1MEN1KMT2A
SCHEMBL20370748 0.76 GSTP1 (0.46) ADORA2AADORA1ALDH1A1MAPTHPGD
SCHEMBL20370694 0.75 DHODH (0.35) —
SCHEMBL24098340 0.75 L3MBTL1 (0.48) L3MBTL1ADORA2AADORA1MEN1KMT2A
SCHEMBL30197451 0.75 L3MBTL1 (0.48) L3MBTL1ADORA2AADORA1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10854823-B2 Heterocyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-12-01 — — US disclosed
US-20180198074-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2018-07-12 — — US disclosed
US-20180198074-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2018-07-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10854823-B2 Heterocyclic compound and organic light-emitting device including the same CRY1, CRY2, CYP1A1 L3MBTL1 1179/4885ADORA2A 3180/4885ADORA1 2441/4885
US-20180198074-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CYP1A1 L3MBTL1 1179/4885ADORA2A 3180/4885ADORA1 2441/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback